Literature DB >> 24510391

Prevalence and relevance of nonalcoholic fatty liver disease in patients with primary sclerosing cholangitis.

Iliana Doycheva1, Kristen Cox, Abdul Haseeb, Douglas G Adler.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24510391     DOI: 10.1007/s10620-014-3051-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  4 in total

1.  Statins and hepatic steatosis: perspectives from the Dallas Heart Study.

Authors:  Jeffrey D Browning
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

2.  Epidemiology of non-alcoholic fatty liver disease.

Authors:  Stefano Bellentani; Federica Scaglioni; Mariano Marino; Giorgio Bedogni
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

3.  Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.

Authors:  Achuthan Sourianarayanane; Gaurav Garg; Thomas H Smith; Mujtaba I Butt; Arthur J McCullough; Bo Shen
Journal:  J Crohns Colitis       Date:  2012-11-15       Impact factor: 9.071

4.  Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.

Authors:  Srinevas K Reddy; Omar Hyder; J Wallis Marsh; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Luca Aldrighetti; David A Geller; Christine Sempoux; Vlad Herlea; Irinel Popescu; Robert Anders; Laura Rubbia-Brandt; Jean-Francois Gigot; Giles Mentha; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-01-25       Impact factor: 3.452

  4 in total
  1 in total

Review 1.  Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Nicha Wongjarupong; Buravej Assavapongpaiboon; Paweena Susantitaphong; Wisit Cheungpasitporn; Sombat Treeprasertsuk; Rungsun Rerknimitr; Roongruedee Chaiteerakij
Journal:  BMC Gastroenterol       Date:  2017-12-08       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.